Bartonella spp. Infections, Thailand

EID Journal Home > Volume 16, Number 4–April 2010

Volume 16, Number 4–April 2010
Letter
Bartonella spp. Infections, Thailand
Saithip Bhengsri, Henry C. Baggett, Leonard F. Peruski Jr, Christina Morway, Ying Bai, Tamara L. Fisk, Anussorn Sitdhirasdr, Susan A. Maloney, Scott F. Dowell, and Michael Kosoy
Author affiliations: Thailand Minstry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand (S. Bhengsri, H.C. Baggett, L.F. Peruski Jr, T.L. Fisk, S.A. Maloney); Thailand Ministry of Public Health, Nonthaburi (A. Sitdhirasdr); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.F. Dowell); and Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (C. Morway, Y. Bai, M. Kosoy)

Suggested citation for this article

To the Editor: Bartonella are fastidious hemotropic gram-negative bacteria with a worldwide distribution. In Thailand, Bartonella species have been demonstrated in mammalian hosts, including rodents, cats and dogs, and in potential vectors, including fleas (1–4). However, data on human infection have been limited to case reports (5,6) and 1 seroprevalence survey, which found a 5.5% prevalence of past B. henselae infection (7). No studies have systematically assessed the frequency, clinical characteristics, or epidemiology of human Bartonella infections in Thailand.

We conducted a prospective study to determine causes of acute febrile illness in 4 community hospitals, 2 in Chiang Rai (northern Thailand) and 2 in Khon Kaen (northeastern Thailand). We enrolled patients >7 years of age with a temperature >38°C who were brought to study hospitals for treatment from February 4, 2002, through March 28, 2003. Patients were excluded if they had a history of fever for >2 weeks or an infection that could be diagnosed clinically. Acute-phase serum samples were collected at the time of enrollment and convalescent-phase serum samples 3–5 weeks later. We enrolled nonfebrile control patients >14 years of age who had noninfectious conditions; acute-phase serum samples were collected. Clinical information was abstracted from patient charts. Nurses conducted physical examinations and personal interviews to collect information on patients' demographic characteristics, exposures to animals, and outdoor activities.

Serum samples were tested for immunoglobulin (Ig) G antibodies to Bartonella spp. by immunofluorescent antibody assay at the Bartonella Laboratory of the Centers for Disease Control and Prevention, Fort Collins, CO, USA. Strains used for antigen production were: B. elizabethae (F9251), B. henselae (Houston-1), B. quintana (Fuller), and B. vinsonii subsp. vinsonii (Baker). Homologous hyperimmune serum specimens were produced in BALB/c mice as previously described (8). Bartonella infection was considered confirmed in febrile patients who had a >4-fold rise in IgG antibody titers and a convalescent-phase titer >64. Probable infection was defined as 1) a 4-fold antibody titer rise but convalescent-phase titers of 64, or 2) high and stable titers (>512 in acute-phase and convalescent-phase serum samples), or 3) acute-phase titer >512 with a >4-fold titer fall. Paired serum samples from febrile patients were also tested for serologic evidence of other common causes of febrile illness in Southeast Asia.

Febrile patients with acute-phase and convalescent-phase IgG antibody titers <128 were considered not to have Bartonella infection; we compared demographic and clinical characteristics of these patients to Bartonella-infected patients. To evaluate potential risk factors, we compared Bartonella-infected case-patients >14 years of age without serologic evidence of other infections (n = 20) to nonfebrile controls with IgG to Bartonella <128 (n = 70). Age adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were calculated.

Serologic testing was completed on paired serum samples for 336 (46%) of 732 febrile patients enrolled; 92 (27%) had serologically confirmed (50) or probable (42) Bartonella infections. Thirty-five (38%) of these 92 had serologic evidence of infection with another pathogen. The remaining 57 Bartonella-infected case-patients (34 confirmed, 23 probable) had a median age of 19 years (range 7–72 years); 65% were males, 47% were students, and 35% were rice farmers. Common clinical characteristics of Bartonella-infected patients included myalgias (83%), chills (79%), and headache (77%). Thirty (60%) patients had anemia (hemoglobin level <13 mg/dL); 18 (32%) had a hemoglobin level <12 mg/dL, and 4 (7%) had <11 mg/dL. When compared with 193 febrile patients without Bartonella infection, the 57 Bartonella-infected patients were similar in age and sex but were more likely to be rice farmers and were more likely to have leukocytosis (Table). Compared with the 70 nonfebrile controls, Bartonella-infected case-patients were more likely to report tick exposure (32% vs. 7.9%; AOR = 5.6, 95% CI 1.5–21) and outdoor activities (55% vs. 31%; AOR = 2.7, 95% CI 1.0–7.4) during the 2 weeks before illness onset. Prevalence of reported rat exposure and animal ownership (cats, dogs, pigs, cows, or buffaloes) was similar among case-patients and controls.

We describe the frequency and clinical characteristics of acute Bartonella infection among febrile patients in Thailand. Over 25% of patients with undifferentiated febrile illness had serologic evidence of Bartonella infection (including 15% serologically confirmed). Our findings indicate that Bartonella infections may be common and underrecognized causes of acute febrile illness in rural Thailand. Although our results are limited by lack of culture confirmation, we used conservative case definitions for serologic diagnosis and therefore believe that most cases represent true Bartonella infections. The common clinical features of anemia and leukocytosis and the frequent tick exposure and outdoor activity are consistent with known features of Bartonella infections and lend support to serologic findings. Because of the potential for serologic cross-reactivity between Bartonella species, we did not attempt species identification. The case-control study was therefore limited by grouping case-patients that were likely infected with different Bartonella species for which risk factors may differ. Such studies could lead to meaningful recommendations for prevention and control of Bartonella infections. Additional epidemiologic and transmission studies are needed to improve understanding of risk factors, identify key animal reservoirs and vectors, and ascertain transmission dynamics.

Acknowledgments
We are grateful for the contributions of the many study collaborators, especially K. Limpakarnjanarat, S. Thamthitiwat, P. Mock, U. Siangphoe, P. Srisaengchai, P. Sawatwong, and A. Nisalak; the dedicated study staff; and all volunteer study participants.

References
Maruyama S, Sakai T, Morita Y, Tanaka S, Kabeya H, Boonmar S, et al. Prevalence of Bartonella species and 16s rRNA gene types of Bartonella henselae from domestic cats in Thailand. Am J Trop Med Hyg. 2001;65:783–7.
Parola P, Sanogo OY, Lerdthusnee K, Zeaiter Z, Chauvancy G, Gonzalez JP, et al. Identification of Rickettsia spp. and Bartonella spp. in fleas from the Thai-Myanmar border. Ann N Y Acad Sci. 2003;990:173–81. PubMed DOI
Castle KT, Kosoy M, Lerdthusnee K, Phelan L, Bai Y, Gage KL, et al. Prevalence and diversity of Bartonella in rodents of northern Thailand: a comparison with Bartonella in rodents from southern China. Am J Trop Med Hyg. 2004;70:429–33.
Suksawat J, Xuejie Y, Hancock SI, Hegarty BC, Nilkumhang P, Breitschwerdt EB. Serologic and molecular evidence of coinfection with multiple vector-borne pathogens in dogs from Thailand. J Vet Intern Med. 2001;15:453–62. PubMed DOI
Kosoy M, Morway C, Sheff KW, Bai Y, Colborn J, Chalcraft L, et al. Bartonella tamiae sp. nov., a newly recognized pathogen isolated from three human patients from Thailand. J Clin Microbiol. 2008;46:772–5. PubMed DOI
Paitoonpong L, Chitsomkasem A, Chantrakooptungool S, Kanjanahareutai S, Tribuddharat C, Srifuengfung S. Bartonella henselae: first reported isolate in a human in Thailand. Southeast Asian J Trop Med Public Health. 2008;39:123–9.
Maruyama S, Boonmar S, Morita Y, Sakai T, Tanaka S, Yamaguchi F, et al. Seroprevalence of Bartonella henselae and Toxoplasma gondii among healthy individuals in Thailand. J Vet Med Sci. 2000;62:635–7. PubMed DOI
Kosoy MY, Regnery RL, Tzianabos T, Marston EL, Jones DC, Green D, et al. Distribution, diversity, and host specificity of Bartonella in rodents from the southeastern United States. Am J Trop Med Hyg. 1997;57:578–88.
Table
Table. Demographic and clinical characteristics of febrile patients with Bartonella infection compared with febrile patients who had no evidence of Bartonella infection, Thailand, 2002–2003

Suggested Citation for this Article
Bhengsri S, Baggett HC, Peruski LF Jr, Morway C, Bai Y, Fisk TL, et al. Bartonella spp. infections, Thailand [letter]. Emerg Infect Dis [serial on the Internet]. 2010 Apr [date cited]. http://www.cdc.gov/EID/content/16/4/743.htm

DOI: 10.3201/eid1604.090699

open here to see the full-text:
http://www.cdc.gov/EID/content/16/4/743.htm